The Vanguard Group 13D and 13G filings for Corvus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-30 1:26 pm Purchase | 2025-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | The Vanguard Group | 3,873,482 5.180% | 3,873,482 (New Position) | Filing |